Dwivedi Alka, Kumar Sushant, Purwar Rahul
Department of Bioscience and Bioengineering, Indian Institute of Technology Bombay (IIT Bombay), Mumbai, Maharashtra, India.
Methods Mol Biol. 2017;1585:217-222. doi: 10.1007/978-1-4939-6877-0_17.
T cell therapy has shown remarkable promise in multiple malignancies including melanoma and Acute Lymphoblastic Leukemia (ALL). Recent data demonstrated the differential efficacy of various subsets of T-helper cells in tumor regression. Th9 cells, the new member of T helper cell family, possess superior anti-tumor activity compared to Th1 and Th2 cells in murine model of melanoma. Therefore, it is important to examine the anti-tumor activity of specific subsets of Th cells in tumor models. Here, we describe the methodology of examining the anti-tumor activity of Th9 cells in murine model of melanoma.
T细胞疗法在包括黑色素瘤和急性淋巴细胞白血病(ALL)在内的多种恶性肿瘤中已显示出显著的前景。最近的数据表明,不同亚群的辅助性T细胞在肿瘤消退中具有不同的疗效。Th9细胞是辅助性T细胞家族的新成员,在黑色素瘤小鼠模型中,与Th1和Th2细胞相比,具有更强的抗肿瘤活性。因此,在肿瘤模型中研究Th细胞特定亚群的抗肿瘤活性具有重要意义。在此,我们描述了在黑色素瘤小鼠模型中检测Th9细胞抗肿瘤活性的方法。